Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (6): 1044-1048. doi: 10.19723/j.issn.1671-167X.2018.06.018

• Article • Previous Articles     Next Articles

A multi-center cross-sectional survey of medicine application in patients with osteoarthritis in China

Xiao-ying ZHANG1,Jia-jing PENG1,Chuan-hui LIU2,Xiao-yan CAI3,Jiang-lin ZHANG4,Yi-fang MEI5,Hong-tao JIN6,Xiao-fei WANG7,Hong MO8,Zhan-guo LI1,()   

  1. 1. Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China
    2. Department of Rheumatology and Immunology, Zhengzhou Orthopaedics Hospital, Zhengzhou 450052, China
    3. Department of Rheumatology and Immunology, Guangzhou First People’s Hospital, Guangzhou 510180, China
    4. Department of Rheumatology and Immunology, Chinese PLA General Hospital, Beijing 100039, China
    5. Department of Rheumatology and Immunology, The First Hospital of Harbin Medical University, Harbin 150001, China
    6. Department of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
    7. Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang 110004, China
    8. Department of Rheumatology and Immunology, Nanning First People’s Hospital, Nanning 530022, China
  • Received:2018-08-04 Online:2018-12-18 Published:2018-12-18
  • Contact: Zhan-guo LI E-mail:li99@bjmu.edu.cn

RICH HTML

  

Abstract:

Objective: To investigate the clinical characteristics, the medicine application and to eva-luate the disease activity in patients with osteoarthritis (OA) in China.Methods:This was a cross-sectional study. Totally 1 066 cases of OA from 40 hospitals in China from April to October 2017 were retrospectively enrolled. Demographic characteristics, clinical data, medicine application, and joint function were evaluated. All the data were analyzed by SPSS software 19.0. t test, Mann-Whitney U test and chi-square test were used for statistical analysis.Results:In the 1 066 cases, the male-to-female ratio was 1 :3.6 and the average age was (61.9±11.0) years, with an age range from 36 to 94 years. The incidence of knee OA, hip OA, and hand OA were respectively 81.9% (873/1 066), 14.1% (150/1 066), and 36.3% (387/1 066). In the study, 242 (22.7%) cases had two kinds of joint areas involved and three joint areas were involved in 51 cases (4.8%), and 56.6% (603/1 066) of the patients used more than one kind of non- steroid anti-inflammatory drugs (NSAIDs) while 61.2% (652/1 066) used disease modifying osteoarthritis drugs (DMOADs), including glucosamine (37.5%, 400/1 066), chondroitin sulfate (2.0%, 21/1 066), diacetate (5.9%, 63/1 066), and the combination of these drugs (15.8%, 168/1 066). 8.6% (92/1 066) patients only took analgesics to relieve the pain, not using any kind of NSAIDs or DMOADs. And 232 patients (21.7%) had intra-articular injections, including 9.2% (98/1 066) sodium hyaluronate, 4.5%(48/1 066) glucocorticoid, and 8.1% (86/1 066) combination of the two drugs. The proportion of the patients taking topical drugs accounted for 26.5% (283/1 066) and physical therapy accounted for 15.8% (168/1 066). Compared with those who suffered from knee OA, the patients who suffered from hip OA had more severe disease assessment. Moreover, there were significant differences in pain (Z=-7.625, P<0.001), morning stiffness (Z=-6.229, P<0.001), and joint function (Z=-6.777, P<0.001) between the two groups of the patients who suffered from knee or hip OA with The Western Ontario and McMaster Universities (WOMAC) osteoarthritis index. Furthermore, patients with hip OA took more analgesics (χ 2=24.838, P<0.001). Conclusion:Oral NSAIDs and DMOADs are wildly used in patients with OA in China. However, the treatment of some patients still need to be improved. Patients with hip OA are more seriously ill and require aggressive treatment.

Key words: Osteoarthritis, Drug therapy, Cross-sectional study

CLC Number: 

  • R593

Table 1

Demographic characteristics of 1 066 osteoarthritis patients"

Items Patients, n(%)
Gender
Female 836 (78.4)
Male 230 (21.6)
Age/years
<45 51 (4.8)
45-<60 402 (37.7)
60-<80 536 (50.3)
≥80 75 (7.0)
Body mass index/(kg/m2)
<18.5 42 (3.9)
18.5-<25.0 561 (52.6)
25.0-<30.0 367 (34.4)
≥30.0 69 (6.5)
Duration/months
<12 225 (21.1)
12-<60 364 (34.1)
60-<120 209 (19.6)
≥120 257 (24.1)
Smoking status
Never smoked 932 (87.4)
Current smoker 80 (7.5)
Ex-smoker 42 (3.9)
Family history
Yes 104 (9.8)
None 944 (88.6)

Table 2

Therapeutics status of 1 066 osteoarthritis patients"

Therapeutics Patients, n(%)
NSAIDs 603 (56.6)
Analgesic 308 (28.9)
DMOADs
Glucosamine 400 (37.5)
Chondroitin 21 (2.0)
Diacerein 63 (5.9)
Combined 2 DMOADs or more 168 (15.8)
Surgical
Arthroplasty 14 (1.3)
Arthroscopy 17 (1.6)
Intra-articular injections
Glucocorticoid 48 (4.5)
Hyaluronate 98 (9.2)
Combined 86 (8.1)
Topical medications 283 (26.5)
Physical therapy 168 (15.8)

Table 3

Clinical characteristics of 909 patients with knee and hiposteoarthritis"

Items Knee OA group (n=759) Hip OA group (n=150) t/Z/χ2 P value
Female, n(%) 602 (73.9) 113 (75.3) 1.183 0.277
Age/years, x-±s 61.4±10.8 65.1±12.2 -3.486 0.001
BMI/(kg/m2), x-±s 24.4±3.4 24.0±3.9 1.284 0.201
Duration/months, median (IQR) 36 (12,108) 60 (22.5,120.0) -2.847 0.004
Assessment from patients/cm, median (IQR) 5 (3,7) 6.0 (4.0,7.1) -4.374 <0.001
Assessment fromphysicians/cm, median (IQR) 5 (3,6) 5.25 (4.0,7.0) -4.719 <0.001
WOMAC score, median (IQR)
Pain 30.0 (11.8,46.0) 48.0 (30.0,63.5) -7.625 <0.001
Stiffness 20.0 (7.5,40.0) 37.5 (20.0,55.0) -6.229 <0.001
Function 28.2 (11.8,49.3) 45.9 (30.3,60.6) -6.777 <0.001
Treatment, patients
NSAIDs, n(%) 414 (54.5) 94 (62.7) 3.351 0.067
Analgesic, n(%) 204 (26.8) 71 (47.3) 24.838 <0.001
DMOADs, n(%) 474 (62.5) 96 (64.0) 0.129 0.720
[1] Tang X, Wang S, Zhan S , et al. The prevalence of symptomatic knee osteoarthritis in China:results from China health and retirement longitudinal study[J]. Arthritis Rheum, 2016,68(3):648-653.
doi: 10.1002/art.39465 pmid: 26474054
[2] 栗占国 . 骨性关节炎的发病机制[J]. 中华全科医师杂志, 2003,2(6):339-340.
[3] Litwic A, Edwards M, Dennison E , et al. Epidemiology and burden of osteoarthritis[J]. Br Med Bull, 2013,105(1):185-199.
doi: 10.1093/bmb/lds038 pmid: 3690438
[4] Dorner T, Stein K . Prevalence and status quo of osteoarthritis in Austria. Analysis of epidemiological and social determinants of health in a representative cross-sectional survey[J]. Wien Med Wochenschr, 2013,163(9/10):206-211.
doi: 10.1007/s10354-013-0174-8
[5] Pang J, Cao YL, Zheng YX , et al. Influence of pain severity on health-related quality of life in Chinese knee osteoarthritis patients[J]. Int J Clin Exp Med, 2015,8(3):4472-4479.
pmid: 26064371
[6] Hiligsmann M, Cooper C, Arden N , et al. Health economics in the field of osteoarthritis: an expert’s consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)[J]. Semin Arthritis Rheum, 2013,43(3):303-313.
doi: 10.1016/j.semarthrit.2013.07.003 pmid: 23992801
[7] Centers for disease control and prevention. Projected state-specific increases in self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitations: United States, 2005—2030[J]. MMWR Morb Mortal Wkly Rep, 2007,56(17):423-425.
pmid: 17476205
[8] Hochberg MC, Altman RD, Brandt KD , et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ.Osteoarthritis of the knee. American College of Rheumatology[J]. Arthritis Rheum, 1995,38(11):1541-1546.
doi: 10.1002/art.1780381103 pmid: 7488273
[9] Hochberg MC, Altman RD, Brandt KD , et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ.Osteoarthritis of the hip. American College of Rheumatology[J]. Arthritis Rheum, 1995,38(11):1535-1540.
doi: 10.1002/art.1780381103 pmid: 7488273
[10] Altman R, Alarcon G, Appelrouth D , et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand[J]. Arthritis Rheum, 1990,33(11):1601-1610.
doi: 10.1002/(ISSN)1529-0131
[11] Allen KD, Bosworth HB, Chatterjee R , et al. Clinic variation in recruitment metrics, patient characteristics and treatment use in a randomized clinical trial of osteoarthritis management[J]. BMC Musculoskelet Disord, 2014,15(1):413.
doi: 10.1186/1471-2474-15-413 pmid: 25481809
[12] Reginato AM, Riera H, Vera M , et al. Osteoarthritis in Latin America: study of demographic and clinical characteristics in 3 040 Patients[J]. J Clin Rheumatol, 2015,21(8):391-397.
doi: 10.1097/RHU.0000000000000281
[13] Sancheti P, Shetty VD, Dhillon MS , et al. India-based knee osteoarthritis evaluation (iKare): a multi-centre cross-sectional study on the management of knee pain and early osteoarthritis in India[J]. Clin Orthop Surg, 2017,9(3):286-294.
doi: 10.4055/cios.2017.9.3.286 pmid: 5567023
[14] Michl GL, Katz JN, Losina E . Risk and risk perception of knee osteoarthritis in the US: a population-based study[J]. Osteoarthritis Cartilage, 2015,24(4):593-596.
doi: 10.1016/j.joca.2015.11.001 pmid: 26555504
[15] 中华医学会风湿病学分会. 骨关节炎诊断及治疗指南[J]. 中华风湿病学杂志, 2010,14(6):416-419.
doi: 10.3760/cma.j.issn.1007-7480.2010.06.024
[16] Kingsbury SR, Hensor EM, Walsh CA , et al. How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the osteoarthritis initiative[J]. Arthritis Res Ther, 2013,15(5):R106.
doi: 10.1186/ar4286
[17] Wise BL, Felson DT, Clancy M , et al. Consistency of knee pain and risk of knee replacement: themulticenter osteoarthritis study[J]. J Rheumatol, 2011,38(7):1390-1395.
doi: 10.3899/jrheum.100743 pmid: 3222910
[18] Cross M, Smith E, Hoy D , et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study[J]. Ann Rheum Dis, 2014,73(7):1323-1330.
doi: 10.1136/annrheumdis-2013-204763
[19] Prasanna SS, Kornerbitensky N, Ahmed S . Why do people delay accessing health care for knee osteoarthritis? Exploring beliefs of health professionals and lay people[J]. Physiother Can, 2013,65(1):56-63.
doi: 10.3138/ptc.2011-50 pmid: 24381383
[1] Qingxin ZHOU,Qingqing YANG,Shuyuan SHI,Pei LI,Feng SUN. Association between serum uric acid and airflow obstruction based on the health-checkup population [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 693-699.
[2] Hongguang LI,Weihua HAN,Xun WU,Jiling FENG,Gang LI,Juanhong MENG. Preliminarily study of arthrocentesis combined with liquid phase concentrated growth factor injection in the treatment of unilateral temporomandibular joint osteoarthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 338-344.
[3] Chun-su ZHU,Zhi-wei LIAN,Yi-min CUI. Association between depression and chronic diseases among middle-aged and older Chinese adults [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 606-611.
[4] Hao WU,Li-ping PAN,Heng LIU,Hong-bin WANG,Tai-guo NING,Yong-ping CAO. Effect of posterior tibial slope on the short-term outcome in mobile-bearing unicompartmental knee arthroplasty [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 877-882.
[5] WU Jun-hui,CHEN Hong-bo,WU Yi-qun,WU Yao,WANG Zi-jing,WU Tao,WANG Meng-ying,WANG Si-yue,WANG Xiao-wen,WANG Jia-ting,YU Huan,HU Yong-hua. Prevalence and risk factors of osteoarthritis in patients with type 2 diabetes in Beijing, China from 2015 to 2017 [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 518-522.
[6] KE Yan,ZHANG Qiang,MA Yun-qing,LI Ru-jun,TAO Ke,GUI Xian-ge,LI Ke-peng,ZHANG Hong,LIN Jian-hao. Short-term outcomes of total hip arthroplasty in the treatment of Tönnis grade 3 hip osteoarthritis in patients with spondyloepiphyseal dysplasia [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 175-182.
[7] Yu-hui LI,Bo SU,Fu-an LIN,Ya-nan FEI,Xiao-xia YU,Wen-qiang FAN,Hai-ying CHEN,Xue-wu ZHANG,Yuan JIA. Cross-sectional study on clinic behavior and therapeutic status of patients with psoriatic arthritis in multi-center [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1014-1018.
[8] WANG Dan-dan, GAN Ye-hua, MA Xu-chen, MENG Juan-hong. Association between ADAMTS14 gene polymorphism and the temporomandibular joint osteoarthritis in Chinese Han females [J]. Journal of Peking University(Health Sciences), 2018, 50(2): 279-283.
[9] CHENG Yin-chu, PAN Yong-ping, ZHANG Yang,PAN Yu-ting, DING Cheng-yi, CAO Yu, ZHUO Lin, FANG Ren-fei, GAO Ai-yu, GUO Jing, LI Ai-jun, FU Qiang, MA Jun, ZHAN Si-yan. Investigation of the cognition and behavior on drug safety in Beijing middle school students [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1038-1043.
[10] WAN Wenli, WANG Jing, ZHU Mingxia,ZHANG Wei, KE Xiaoyan. Retrospective analyses of CHOPE plus L-asparaginase regimen in treatment of T-cell lymphoma [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 841-845.
[11] LI Zhi-chang, JIANG Long, ZHANG Shu, QIN Xue-ying, Daniel K. White PT,HOU Yun-fei, ZHOU Zhi-wei, LIN Jian-hao. Evaluation of physical function for the end-stage osteoarthritis patient waiting for the total knee replacement [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 257-262.
[12] LI Wei, JIANG Chun-yan, WANG Zhan-wei, XIAO De-ming. Intraarticular injection of bevacizumab in treatment of osteoarthritis: a laboratory research on a rabbit model [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 203-209.
[13] PAN Li-ping, CAO Yong-ping, WEN Li-cheng, CHAI Wei-bing, DU Jun-bao, JIN Hong-fang, LIU Jia, YANG Xin, MENG Zhi-chao, LIU Heng, CUI Yun-peng, WANG Rui, WU Hao, ZHOU Xing-tong, LI Xiang. Hydrogen sulfide in cartilage and its inhibitory effect on matrix metalloproteinase 13 expression in chondrocytes induced  by interlukin-1β [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 194-201.
[14] ZHU Yi-Ming, JIANG Chun-Yan, LU Yi, LI Feng-Long, LI Xu, LI Yue. Clinical follow-up study after open Latarjet procedure in patients with recurrent anterior shoulder dislocation [J]. Journal of Peking University(Health Sciences), 2015, 47(2): 226-231.
[15] CUI Yun-Peng, CAO Yong-Ping, LIU Heng, YANG Xin, MENG Zhi-Chao, WANG Rui. Bone marrow mesenchymal stem cells in Sprague-Dawley rat model of osteoarthritis [J]. Journal of Peking University(Health Sciences), 2015, 47(2): 211-218.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!